SCHEMBL27435544

SCHEMBL27435544

COC(=O)/C=C/COC(C)c1cccc2c(=O)n(Cc3ccc(OC)cc3)ncc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 12/20 0.42
▸ AURKA O14965 1/20 0.41
▸ AURKB Q96GD4 1/20 0.41
▸ MCHR1 Q99705 1/20 0.39
▸ GPR139 Q6DWJ6 2/20 0.39
▸ PKM P14618 2/20 0.38
▸ PKLR P30613 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PDE1A P54750 1/20 0.37
▸ PDE1B Q01064 1/20 0.37
▸ PDE1C Q14123 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987354 0.88 NPBWR1 (0.41) NPBWR1AURKAAURKBMCHR1GPR139
SCHEMBL29987686 0.88 NPBWR1 (0.43) NPBWR1MCHR1GPR139PKMPKLR
SCHEMBL27435484 0.88 NPBWR1 (0.43) NPBWR1MCHR1GPR139PKMPKLR
SCHEMBL27435541 0.81 NPBWR1 (0.43) NPBWR1AURKAAURKBMCHR1GPR139
SCHEMBL27435547 0.81 NPBWR1 (0.53) NPBWR1AURKAAURKBMCHR1PKM
SCHEMBL27435536 0.80 NPBWR1 (0.43) NPBWR1MCHR1GPR139PKMPKLR
SCHEMBL27077708 0.80 NPBWR1 (0.41) NPBWR1AURKAAURKBMCHR1GPR139
SCHEMBL27077737 0.80 NPBWR1 (0.43) NPBWR1MCHR1GPR139PKMPKLR
SCHEMBL27077642 0.77 NPBWR1 (0.49) NPBWR1AURKAAURKBMCHR1PKM
SCHEMBL27077835 0.71 NPBWR1 (0.54) NPBWR1AURKAAURKBMCHR1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217968-A1 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2024-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217968-A1 PHARMACEUTICAL COMPOUND F11, F12, ZYX NPBWR1 830/4885AURKA 3052/4885AURKB 2318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback